StockData
Cryo-Cell International Inc logo

Cryo-Cell International Inc (CCEL) stock

CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026Score 2/30
$4.55−0.30 (-6.19%)

Close on Nov 16, 2026Market cap $36.69MP/E –Yield –

Cryo-Cell International revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Cryo-Cell International's revenue for the twelve months ending Aug 31, 2026 was $31.13M, down 2.0% year over year. For fiscal 2025 it was $31.57M, down 1.3% from the year before. Over ten years it grew 4.1% a year on average. The highest annual figure on record is $31.99M in fiscal 2024.

Annual revenue

PeriodPeriod endValueChange
FY2025Nov 30, 2025$31.57M-1.3%
FY2024Nov 30, 2024$31.99M+2.0%
FY2023Nov 30, 2023$31.34M+3.3%
FY2022Nov 30, 2022$30.34M+5.0%
FY2021Nov 30, 2021$28.88M-7.3%
FY2020Nov 30, 2020$31.15M-2.1%
FY2019Nov 30, 2019$31.82M+8.9%
FY2018Nov 30, 2018$29.22M+15.1%
FY2017Nov 30, 2017$25.38M+9.8%
FY2016Nov 30, 2016$23.13M+9.7%
FY2015Nov 30, 2015$21.09M+4.8%
FY2014Nov 30, 2014$20.13M+6.0%
FY2013Nov 30, 2013$18.99M+5.7%
FY2012Nov 30, 2012$17.97M+0.3%
FY2011Nov 30, 2011$17.92M+0.9%
FY2010Nov 30, 2010$17.76M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ3 2026Aug 31, 2026$7.82M-0.0%
Q2 FY2026CQ2 2026May 31, 2026$7.78M-1.9%
Q1 FY2026CQ1 2026Feb 28, 2026$7.68M-3.6%
Q4 FY2025CQ4 2025Nov 30, 2025$7.84M-2.3%
Q3 FY2025CQ3 2025Aug 31, 2025$7.83M-3.0%
Q2 FY2025CQ2 2025May 31, 2025$7.93M-1.4%
Q1 FY2025CQ1 2025Feb 28, 2025$7.97M+1.5%
Q4 FY2024CQ4 2024Nov 30, 2024$8.02M+1.9%
Q3 FY2024CQ3 2024Aug 31, 2024$8.07M+2.5%
Q2 FY2024CQ2 2024May 31, 2024$8.04M+3.5%
Q1 FY2024CQ1 2024Feb 29, 2024$7.85M+0.4%
Q4 FY2023CQ4 2023Nov 30, 2023$7.88M+1.5%
Q3 FY2023CQ3 2023Aug 31, 2023$7.87M+2.5%
Q2 FY2023CQ2 2023May 31, 2023$7.77M+1.8%
Q1 FY2023CQ1 2023Feb 28, 2023$7.82M+7.8%
Q4 FY2022CQ4 2022Nov 30, 2022$7.76M+6.1%
Q3 FY2022CQ3 2022Aug 31, 2022$7.68M+2.4%
Q2 FY2022CQ2 2022May 31, 2022$7.63M+5.9%
Q1 FY2022CQ1 2022Feb 28, 2022$7.26M+5.8%
Q4 FY2021CQ4 2021Nov 30, 2021$7.32M-3.0%
Q3 FY2021CQ3 2021Aug 31, 2021$7.50M-7.5%
Q2 FY2021CQ2 2021May 31, 2021$7.21M-8.5%
Q1 FY2021CQ1 2021Feb 28, 2021$6.86M-10.0%
Q4 FY2020CQ4 2020Nov 30, 2020$7.54M-5.4%
Q3 FY2020CQ3 2020Aug 31, 2020$8.11M-1.3%
Q2 FY2020CQ2 2020May 31, 2020$7.87M-3.1%
Q1 FY2020CQ1 2020Feb 29, 2020$7.62M+1.7%
Q4 FY2019CQ4 2019Nov 30, 2019$7.97M-7.3%
Q3 FY2019CQ3 2019Aug 31, 2019$8.22M+4.5%
Q2 FY2019CQ2 2019May 31, 2019$8.13M+24.6%
Q1 FY2019CQ1 2019Feb 28, 2019$7.50M+20.3%
Q4 FY2018CQ4 2018Nov 30, 2018$8.59M+32.7%
Q3 FY2018CQ3 2018Aug 31, 2018$7.87M+14.1%
Q2 FY2018CQ2 2018May 31, 2018$6.53M+4.6%
Q1 FY2018CQ1 2018Feb 28, 2018$6.23M+7.8%
Q4 FY2017CQ4 2017Nov 30, 2017$6.47M+10.3%
Q3 FY2017CQ3 2017Aug 31, 2017$6.90M–
Q2 FY2017CQ2 2017May 31, 2017$6.24M–
Q1 FY2017CQ1 2017Feb 28, 2017$5.78M–
Q4 FY2016CQ4 2016Nov 30, 2016$5.87M–

More Cryo-Cell International figures

See a number that looks wrong?